Pandemic threat? Anyone else concerned?

David L

IPCT Contributor
Joined
Aug 2, 2019
Messages
8,017
Reaction score
20,999
Location
USA
I’ve seen far more that say it does, including numerous original FDA/NIH data…. Google it

As I understand it, The thing with Ivermectin, or any protease inhibitor (including Pfizermectin/Paxlovid ;) is that they help block the virus from entering cells. Which means they have to be taken early in the first couple of days to show benefit. After that, the bug has invaded so many cells already that it’s too late to block them.
( it’s a far more complex affair than what I just described but that’s the layman’s version as I understand it)

The FLCCC protocol I follow includes preventative dosage and also includes other drugs and supplements. So while Ivermevtin is key, it’s not the only treatment.

I’ve seen a lot about vitamin D3/zinc and more recently melatonin as being big parts to prevention/early treatment as well.
The other thing known is Ivermectin does real well in the lungs making it great for treating things that attack the lungs. I truly believe it helped my Covid bout...I had hardly any breathing issues even though I had 102 fever...
 

Oceanslider

Known around here
Joined
Dec 1, 2019
Messages
6,962
Reaction score
23,811
Location
Southern California, USA
As I have said before, show me one case where Ivermectin killed someone and I will show you thousand's of cases where Remdesivir has...
Exactly. This is the biggest human scam tragedy in my lifetime. And I will bet you it's in the 100's of Thousands. How many autopsy's were preformed after death?
 

Oceanslider

Known around here
Joined
Dec 1, 2019
Messages
6,962
Reaction score
23,811
Location
Southern California, USA
I'd laugh at this one but this guy is such a joke to humanity, he just pisses me off anytime he comes on the radar.
 
Joined
Apr 21, 2021
Messages
16
Reaction score
3
Location
cali
One of many early studies



Here’s a recent one
Conclusion
Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir. To our knowledge, this is the largest association study of patients with COVID-19, mortality and ivermectin.
Plastic surgeons created this study. Nothing wrong with that but what is their background in infectious disease lol
 

bigredfish

Known around here
Joined
Sep 5, 2016
Messages
17,322
Reaction score
48,374
Location
Floriduh
Plastic surgeons created this study. Nothing wrong with that but what is their background in infectious disease lol
ummm not what I’m reading…

Study conception and design: P. Kory and G. U. Meduri.


Acquisition of data: Paul Marik and Jose Iglesias. Analysis and interpretation of data: Paul Marik, P. Kory, and Jose Iglesias. Drafting of manuscript: P. Kory. Critical revision: G. U. Meduri and Joseph Varon.

And the data was largely gathered from over 80 papers and studies listed at the bottom of the article.

As stated this is simply one of many many early studies, over 60 peer reviewed.
 
Last edited:

bigredfish

Known around here
Joined
Sep 5, 2016
Messages
17,322
Reaction score
48,374
Location
Floriduh
Plastic surgeons created this study. Nothing wrong with that but what is their background in infectious disease lol
And if you’re referencing this study, they are researchers crunching numbers from publicly available data. They did no medical study themselves


Purpose
To evaluate the difference in mortality of patients treated with ivermectin vs patients treated with remdesivir with COVID-19 in United States using TriNetX Research network, a federated EMR network of over 44 healthcare organizations and 68 million patients from US, from 2009-2021.
Methods & Materials
We retrospectively identified adults (≥18 years) with a recorded COVID-19 infection between January 1, 2020 and July 11, 2021. We compared those with recorded use of ivermectin, but not remdesivir, against those with recorded use of remdesivir, but not ivermectin. We controlled for the following demographics, comorbidities, and treatments that may affect COVID-19 survival outcomes: age, gender, race, ethnicity, nicotine use diabetes mellitus, obesity, chronic lower respiratory disease, ischemic heart diseases, tocilizumab, glucocorticoids, or ventilator use. We measured association with mortality as the primary outcome, with significance assessed at p<0.05.
Results
There were a total of 1,761,060 possible COVID-19 patients based on ICD-10 diagnostic terms and confirmatory lab results. Prior to controlling, our analysis yielded 41,608 patients who had COVID-19 resulting in two unique cohorts that were treated with either ivermectin (1,072) or remdesivir (40,536). Within the ivermectin cohort, average age was 51.9 + 17.8 years, 43% were male, 60% had glucocorticoids and 1% required ventilator support. In the remdesivir cohort, average age was 62.0 + 16.0 years, 54% were male, 64% had glucocorticoids and 2% required ventilator support. After using propensity score matching and adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir (OR 0.308, 95% CI (0.198,0.479)),Risk Difference -5.224%, CI (-7.079%,-3.369%), p <0.0001.
 
Top